Topics

In our October Issue: As #ArtificialIntelligence moves into clinical trials, consideration is needed on whether the current #CONSORT and #SPIRIT reporting statements are sufficient to ensure transparency #MachineLearning | http://go.nature.com/2mRr61l 

17:46 EDT 7 Oct 2019 | Nature Publishing

In our October Issue: As moves into clinical trials, consideration is needed on whether the current and reporting statements are sufficient to ensure transparency | http://go.nature.com/2mRr61l  |

Original Article: In our October Issue: As #ArtificialIntelligence moves into clinical trials, consideration is needed on whether the current #CONSORT and #SPIRIT reporting statements are sufficient to ensure transparency #MachineLearning | http://go.nature.com/2mRr61l 

NEXT ARTICLE

More From BioPortfolio on "In our October Issue: As #ArtificialIntelligence moves into clinical trials, consideration is needed on whether the current #CONSORT and #SPIRIT reporting statements are sufficient to ensure transparency #MachineLearning | http://go.nature.com/2mRr61l  "

Quick Search

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...